Concepedia

Eva B. Allerbring

EB

3

Publications

58

Citations

3

H-Index

2012

Active since

Affiliations

AlbaNova(Current)

KTH Royal Institute of Technology

Karolinska University Hospital

Karolinska Institutet

Science for Life Laboratory

Eva B. Allerbring is an author at AlbaNova specializing in immunology, medicine, and immunodominance.

ORCID

Top concepts

Publications per year

2012–2020

3

Publications

3

Proline substitution independently enhances <scp>H</scp>‐2<scp>D</scp><sup>b</sup> complex stabilization and <scp>TCR</scp> recognition of melanoma‐associated peptides

Hannes Uchtenhagen, Esam T. Abualrous, Evi Stahl et al. · European Journal of Immunology · 2013 · 25 citations

Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination

Adil Doganay Duru, Renhua Sun, Eva B. Allerbring et al. · PLoS Pathogens · 2020 · 21 citations · Full text

, , +17

Unexpected <scp>T</scp>‐cell recognition of an altered peptide ligand is driven by reversed thermodynamics

Eva B. Allerbring, Adil Doganay Duru, Hannes Uchtenhagen et al. · European Journal of Immunology · 2012 · 12 citations · Full text

, , +20

Rows per page

1–3 of 3